AbbVie Inc. Profile Avatar - Palmy Investing

AbbVie Inc.

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psori…
Drug Manufacturers - General
US, North Chicago [HQ]
Growth Rates · Payout · Yield

Dividends Over Time

Searching for a Dividend Aristocrat? Sign Up to view the entire dividend history of AbbVie Inc.

Growth Rates
5.38% YoY
19.38% 3Yr
46.04% 5Yr
289.91% 10Yr
Key Metrics
3% TTM Yield
- - Average Days Gap
Series
1.55 DPS
202.48% Payout Ratio
End of ABBV's Analysis
CIK: 1551152 CUSIP: 00287Y109 ISIN: US00287Y1091 LEI: - UEI: -
Secondary Listings